Company

Key Facts

Established in 2021

Founded on breakthrough technology developed at MIT's Research Laboratory of Electronics and Singapore MIT Alliance for Research and Technology.

Partnerships

Partnered with leading healthcare companies and medical research hospitals across the globe, actively forming new strategic partnerships.

Intellectual Property

Intellectual property portfolio includes 2 issued and 5 pending patents focused on microscale magnetic resonance technology for measuring oxidative stress in blood and life science diagnostics.

Peer-Reviewed

12 peer-reviewed publications validating LarmorBio’s importance in clinical diagnostics and life science research.

4,000 Patient Studies

Currently used in studies worldwide, representing thousands of patients in major disease areas impacting human health.

Management Team

CEO and Founder

CFO

CSO

Stan Sassower M.S

VP of Engineering

Scientific Advisory Board

Yie Hou PhD

Inventor